[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-296224-105":59,"doc-detail-296224-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","clinical-research-compliance-with-documentation-of-high-risk-medications-in-the-post-anaesthetic-care-unit","Clinical Research - Compliance with Documentation of “High Risk Medications” in the Post Anaesthetic Care Unit","","Clinical research materials examining compliance and documentation practices in the Post Anaesthetic Care Unit (PACU). The project reviews adherence to “High Risk Medications” documentation on the National Inpatient Medication Chart (NIMC) and the Automated Anaesthetic Record Keeping (AARK) system using quantitative dose audits and a one-month data collection period. A baseline audit shows low documentation and monitoring of pain protocol dosing, followed by improvement after targeted education and implementation. A related case report describes headache symptoms during home parenteral nutrition infusions, linked to plasticizer toxicity, with management and resolution after switching PN bag materials.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/clinical-research-compliance-with-documentation-of-high-risk-medications-in-the-post-anaesthetic-care-unit/296224/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/clinical-research-compliance-with-documentation-of-high-risk-medications-in-the-post-anaesthetic-care-unit/296224.png","ImageObject",300,407,{"name":92,"@type":93},"Bulrr","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-22","2026-09-18",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What was the purpose of the PACU clinical research project?","Question",{"text":113,"@type":114},"To review PACU practice and assess compliance with documentation for “High Risk Medications” on the NIMC and AARK systems.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were compliance barriers identified and what was implemented afterward?",{"text":118,"@type":114},"Quantitative data were collected over one month, dose audits were analyzed, and barriers were identified; education was then provided to PACU staff after the initial audits.",{"name":120,"@type":111,"acceptedAnswer":121},"What caused the unusual headaches reported during home parenteral nutrition infusions?",{"text":122,"@type":114},"The case report attributes the symptoms most likely to plasticizer toxicity, associated with DEHP-containing PN bags.",{"name":124,"@type":111,"acceptedAnswer":125},"What evidence showed improvement and what was the eventual outcome in the case?",{"text":126,"@type":114},"After implementation, documentation compliance improved on AARK and NIMC; for the case, headaches resolved after changing bags from PVC-DEHP to latex due to a product recall and subsequent follow-up.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},296224,1789729803,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":144,"language":145,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":67,"update_tm":134,"read_time":149},5909892115043,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Clinical Research  \nID \\#CLIN-0016  \nCompliance with Documentation of “High Risk Medications” in the Post Anaesthetic Care Unit  \nPurpose  \n(PACU)  \nAshleigh McIntosh1, Lucie Offer2, Hannah Keen3 . Jed Duff4 . Anna Doubrovsky5 Madonna Cameron6 . 1. RBWH PACU  \nHigh risk medications (HRMs) have been shown to cause significant harm or death if not administered  \nRoyal Brisbane & Women’s Hospital  \nPACU APINCHs Medication Audit Comparision between 2021/2022  \ncorrectly.  \nMethods  \nAll medications except Pain Protocol  \nThe aim of this project is to review practice in PACU and the compliance of documentation for “High Risk Medications” on the National Inpatient Medication Chart (NIMC) and on the Automated Anaesthetic Record Keeping (AARK) system. The team collected quantitative data over a one-month period and identified any barriers preventing compliance with documentation. A total of 123 dose audits were collected at baseline (June, 2021) and 101 dose audits post implementation (February, 2022)  \nResults  \nIV Mg/K/Ca  \nIV Antibiotics  \nIV Cardiac  \nIV Antiemetics  \nPO Opiate  \nThe pre- implementation audit showed that forty-four (44%) of PACU staff didn’t double check and document the pain protocol dose in AARK. Audits of APINCHs drugs on the NIMC showed that only seventy-six (76%) of staff were observed to correctly document these drugs. Education was provided to PACU staff post these audits. This included in-servicing, an educational lanyard given to staff and a pledge board.  \nIV Paracetamol  \n2021  \n 2 × Signatures in NIMC Nil Signatures in NIMC  \n2 × Signatures in NIMC Nil signatures recorded on NIMC  \nResults  \nA post implementation audit was completed, and results showed a significant improvement of twenty seven (27%) in which staff were correctly documenting the opioid pain protocol on AARK. Results from the audits on APINCHs showed a twenty-one (21%) increase of staff correctly documenting on the NIMC. During the in-services it was indicated by some nursing staff that they were unaware of the correct method of documentation. This was addressed and created good clinical discussions amongst the staff. These results are extremely positive and show that staff are now following the correct procedure for documenting high risk drugs within PACU.  \nConclusion  \nBy adhering to the hospital policy and procedure we should see a decrease in the amount of documentation errors within PACU leading to positive patient outcomes.  \nCLIN-0037  \nAn Unusual Cause of Headaches during Home Parenteral Nutrition Infusions-A Case Report and Management Strategy.  \nAdris N1, Kaushik V1 , Osland E2, Watt A2,  \n1. Department of Gastroenterology & Hepatology, Royal Brisbane & Women’s Hospital (RBWH), QLD, Australia.  \n2. Department of Nutrition & Dietetics, Royal Brisbane & Women’s Hospital (RBWH), QLD, Australia.  \nINTRODUCTION  \n• Parenteral Nutrition (PN) is a life-saving treatment for patients who cannot meet their nutritional requirements via oral or enteral routes.  \n• Short bowel syndrome is the most common indication for long term home PN (HPN) .  \n• Despite its benefits, PN may be associated with complications such as metabolic abnormalities, cholestasis, central line associated blood stream infections and thrombosis.  \n• Symptoms that occur exclusively during PN infusions are uncommon and challenging to diagnose and treat.  \n• We hereby report a case of a patient with severe headaches during PN infusions that was most likely caused by plasticizer toxicity and make suggestions for strategies to manage this symptom.  \nCASE REPORT  \nA 53-year-old female on HPN for 7 years for short gut syndrome secondary to surgical resections to treat fistulizing small & large bowel Crohn’s disease complained of headaches during PN infusions. She never suffered from headaches preceding the use of HPN. There was a consistent pattern of symptom onset at the final hours of every HPN infusion. She described the headaches as dull, generalized and throbbing withou","cbCaieJIV1YKhkyo","https://ap.wps.com/l/cbCaieJIV1YKhkyo","pdf",10893588,103,"English","# Purpose\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Case report\n## Investigations\n## Outcome","[{\"question\":\"What was the purpose of the PACU clinical research project?\",\"answer\":\"To review PACU practice and assess compliance with documentation for “High Risk Medications” on the NIMC and AARK systems.\"},{\"question\":\"How were compliance barriers identified and what was implemented afterward?\",\"answer\":\"Quantitative data were collected over one month, dose audits were analyzed, and barriers were identified; education was then provided to PACU staff after the initial audits.\"},{\"question\":\"What caused the unusual headaches reported during home parenteral nutrition infusions?\",\"answer\":\"The case report attributes the symptoms most likely to plasticizer toxicity, associated with DEHP-containing PN bags.\"},{\"question\":\"What evidence showed improvement and what was the eventual outcome in the case?\",\"answer\":\"After implementation, documentation compliance improved on AARK and NIMC; for the case, headaches resolved after changing bags from PVC-DEHP to latex due to a product recall and subsequent follow-up.\"}]","Clinical Research - Compliance with Documentation of “High Risk Medications” in the Post Anaesthetic Care Unit | PDF",260]